Genomic profiling of the FaDu cell line and derived subclones using amplicon-based targeted sequencing
Ontology highlight
ABSTRACT: Mutational profiling by targeted next-generation sequencing of a SCCHN cell line model and single-cell derived subclones displaying varying sensitivity to cisplatin was used to determine the extent of intratumoral heterogeneity and to dissect the molecular mechanisms involved in primary cisplatin resistance and treatment-induced clonal evolution.
INSTRUMENT(S): Illumina MiSeq
ORGANISM(S): Homo sapiens
SUBMITTER: Ingeborg Tinhofer
PROVIDER: E-MTAB-6021 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA